About The Position

The Senior Director leads early drug product formulation, process development, and outsourced clinical manufacturing, with emphasis on first-in-human and Phase 2 programs. The role combines formulation and pre-formulation experience with expertise in spray drying, tableting, and parenteral products, along with experience with PEG-containing candidates and working knowledge of biologics formulation. The incumbent directs external partners, mentors staff, and owns functional delivery and budgets. The position requires demonstrated success advancing multiple programs through IND-enabling development and Phase 1/2. The Senior Director is expected to make creative, efficient, scientifically justified decisions with clear mitigation plans while protecting patient safety, product quality, and compliance. Later-stage development and commercialization experience are desirable but not required. This position reports to the Head of Technical Operations and may be remote, hybrid, or based at Arvinas headquarters in New Haven, Connecticut. Duties are generally performed in a combination of company office and home office environments. Employees must maintain general availability during standard business hours and be able to work in a controlled environment around biological, infectious, and hazardous materials, gown and degown PPE, use a computer, communicate by phone, video, and electronic messaging, and collaborate and solve problems with others. The role requires the ability, with or without accommodation, to lift or carry 15 pounds unassisted or 30 pounds assisted. A Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline with typically 15 or more years of relevant pharmaceutical or biotechnology experience is expected, or a bachelor’s or master’s degree with typically 20 or more years. Experience must include substantial drug product leadership and repeated early clinical delivery; equivalent combinations of education and relevant experience may be considered. Arvinas will not provide current or future visa sponsorship.

Requirements

  • Repeated success developing and delivering formulations for multiple IND-enabling and Phase 1/2 programs, adapting presentations and processes as dose, material availability, and clinical needs evolve.
  • Experience in early formulation and pre-formulation, including interpreting compound characterization and applying it to product development.
  • Spray drying and tableting experience, including amorphous solid dispersions, formulation and process optimization, and transfer to clinical manufacturing partners.
  • Parenteral formulation experience, including injectable development and technical oversight of sterile manufacturing vendors.
  • Experience with PEG derivatives or PEG-containing drug candidates, plus working knowledge of biologics formulation, including stability, aggregation, adsorption, and excipient selection.
  • Strong CDMO management, clinical CMC submission, and phase-appropriate cGMP experience.
  • Demonstrated creativity, calculated risk assessment, team leadership, budget ownership, and cross-functional delivery.
  • Ability to provide senior functional leadership while staying closely involved in technical reviews, vendor decisions, and problem-solving.
  • Ability to document assumptions, decision criteria, risks, and mitigation, and distinguish current-stage evidence and controls from work that can appropriately follow later.
  • Ability to develop internal talent and collaborate effectively across relevant functions and project teams.
  • Ph.D. in Pharmaceutics, Pharmaceutical Sciences, Chemistry, Chemical Engineering, or a related discipline with typically 15 or more years of relevant pharmaceutical or biotechnology experience; alternatively, a bachelor’s or master’s degree with typically 20 or more years. Equivalent combinations of education and relevant experience may be considered.
  • Must be able to work without current or future visa sponsorship.
  • With or without accommodation, ability to lift/carry 15 pounds unassisted or 30 pounds assisted; work in a controlled environment with and around biological, infectious, and hazardous materials; gown and degown PPE; use a computer; communicate through phone, video, and electronic messaging; engage in problem-solving, analysis, dialogue, and collaboration; and maintain general availability during standard business hours.

Nice To Haves

  • Later-stage development and commercialization experience.

Responsibilities

  • Lead drug product strategy and execution for IND-enabling support, first-in-human studies, and Phase 2, defining formulation options, decision criteria, timelines, budgets, and mitigation plans.
  • Interpret solubility, solid-state, dissolution, stability, and excipient compatibility data, and work with Pre-formulation to translate findings into practical formulations and resolve knowledge gaps.
  • Direct spray drying and amorphous solid dispersion development, including polymer and solvent selection, drug loading, residual solvent control, physical stability, scale-up, and technology transfer.
  • Lead tablet formulation and process development, including blending, compression or granulation, and coating as appropriate; address manufacturability, content uniformity, and dissolution.
  • Lead parenteral formulation development, including solutions and/or lyophilized products, excipient and container selection, stability, dilution, and administration compatibility.
  • Assess formulation implications of PEG derivatives and PEG-containing candidates and apply working knowledge of biologics formulation; engage specialists as needed.
  • Select and manage CDMOs for formulation, oral solid dosage manufacture, and sterile products; own technical scopes, transfers, manufacturing readiness, vendor performance, and delivery against approved plans.
  • Partner with Analytical Development and Quality Assurance on specifications, release testing, stability, shelf life, and in-use requirements.
  • Ensure appropriate sterility assurance, contamination controls, and container-closure integrity with qualified sterile manufacturers.
  • Lead drug product content for INDs and clinical amendments, coordinate clinical manufacture and handover to Clinical Supply, manage budgets and staff, resolve investigations and changes with Quality Assurance, and communicate technical options and supply risks.
  • Provide senior functional leadership while remaining closely involved in technical reviews, vendor decisions, and problem-solving.
  • Distinguish evidence and controls needed for the current stage from work that can appropriately follow later; document assumptions, decision criteria, risks, and mitigation.
  • Develop internal talent and collaborate across Drug Substance, Drug Product, Analytical Development, Clinical Supply, Quality Assurance, CMC Regulatory Affairs, and project teams.

Benefits

  • Competitive base and incentive compensation.
  • Comprehensive benefits program designed to support employees’ and their families’ health, wellness, and financial security.
  • Group medical coverage.
  • Vision coverage.
  • Dental coverage.
  • Group and supplemental life insurance.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service